Published in Clin Biochem on October 01, 2003
Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis (2011) 7.41
Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology (2011) 2.39
Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev (2013) 1.82
Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest (2011) 1.49
Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline. World J Gastroenterol (2007) 1.34
The biogenesis of chylomicrons. Annu Rev Physiol (2010) 1.32
The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation. PLoS Pathog (2013) 1.24
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. Clin Med Insights Cardiol (2015) 1.19
Non-invasive assessment of barrier integrity and function of the human gut. World J Gastrointest Surg (2010) 1.16
Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia. PLoS One (2012) 1.03
Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population. PLoS One (2013) 1.01
Diagnosis and management of splanchnic ischemia. World J Gastroenterol (2008) 0.99
Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy. PLoS One (2013) 0.98
Rapid development of intestinal cell damage following severe trauma: a prospective observational cohort study. Crit Care (2009) 0.96
Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial. HIV Med (2014) 0.94
Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics (2007) 0.93
Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine. Prostaglandins Leukot Essent Fatty Acids (2014) 0.91
Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease. Gut (2016) 0.90
Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast Brazil. PLoS One (2016) 0.87
Serum markers and intestinal mucosal injury in chronic gastrointestinal ischemia. Dig Dis Sci (2010) 0.86
Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma. Mol Cell Proteomics (2014) 0.85
Role of heat-stable enterotoxins in the induction of early immune responses in piglets after infection with enterotoxigenic Escherichia coli. PLoS One (2012) 0.85
Genome-wide analysis of the rat colon reveals proximal-distal differences in histone modifications and proto-oncogene expression. Physiol Genomics (2013) 0.85
Usefulness of intestinal fatty acid-binding protein in predicting strangulated small bowel obstruction. PLoS One (2014) 0.84
Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity. World J Gastroenterol (2016) 0.84
Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals. PLoS Pathog (2014) 0.83
Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes. Histochem Cell Biol (2007) 0.83
Interaction of enterocyte FABPs with phospholipid membranes: clues for specific physiological roles. Biochim Biophys Acta (2011) 0.82
The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon. Nutr Rev (2011) 0.82
Extensive expression differences along porcine small intestine evidenced by transcriptome sequencing. PLoS One (2014) 0.81
Insights from human congenital disorders of intestinal lipid metabolism. J Lipid Res (2014) 0.81
Loss of intestinal GATA4 prevents diet-induced obesity and promotes insulin sensitivity in mice. Am J Physiol Endocrinol Metab (2010) 0.81
Gene expression profiling of jejunal Peyer's patches in juvenile and adult pigs. Mamm Genome (2005) 0.81
Urinary Intestinal Fatty Acid-Binding Protein Can Distinguish Necrotizing Enterocolitis from Sepsis in Early Stage of the Disease. J Immunol Res (2016) 0.80
Value of the serum I-FABP level for diagnosing acute mesenteric ischemia. Surg Today (2013) 0.80
The intestinal barrier as an emerging target in the toxicological assessment of mycotoxins. Arch Toxicol (2016) 0.79
Recent insights into the biological functions of liver fatty acid binding protein 1. J Lipid Res (2015) 0.79
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury. Liver Int (2016) 0.79
The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals. J Infect Dis (2015) 0.79
The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity. Nutr Metab (Lond) (2016) 0.78
Effects of silver nanoparticles and ions on a co-culture model for the gastrointestinal epithelium. Part Fibre Toxicol (2016) 0.78
Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection. Mucosal Immunol (2016) 0.77
Expression Pattern of Fatty Acid Binding Proteins in Celiac Disease Enteropathy. Mediators Inflamm (2015) 0.77
Accuracy of the serum intestinal fatty-acid-binding protein for diagnosis of acute intestinal ischemia: a meta-analysis. Sci Rep (2016) 0.77
Association of a Human FABP1 Gene Promoter Region Polymorphism with Altered Serum Triglyceride Levels. PLoS One (2015) 0.77
Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure. Hepatology (2016) 0.75
Temporal profile of intestinal tissue expression of intestinal fatty acid-binding protein in a rat model of necrotizing enterocolitis. Clinics (Sao Paulo) (2016) 0.75
Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease. PLoS One (2016) 0.75
Monocyte Activation is Associated with Worse Cognitive Performance in Virologically Suppressed HIV-Infected Women. J Infect Dis (2016) 0.75
Cytokine-like Activity of Liver Type Fatty Acid Binding Protein (L-FABP) Inducing Inflammatory Cytokine Interleukin-6. Immune Netw (2016) 0.75
Bowel Ischemia in ICU Patients: Diagnostic Value of I-FABP Depends on the Interval to the Triggering Event. Gastroenterol Res Pract (2017) 0.75
Intestinal barrier integrity and function in infants with cholestasis. Intest Res (2017) 0.75
Intestinal fatty-acid binding protein and metronidazole response in premature infants. J Neonatal Perinatal Med (2014) 0.75
Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication. PLoS Pathog (2016) 0.75
Novel potential interacting partners of fibronectin in spontaneous animal model of interstitial cystitis. PLoS One (2012) 0.75
Prediction of Gut Wall Integrity Loss in Viral Gastroenteritis by Non-Invasive Marker. Open Access Maced J Med Sci (2015) 0.75
Intestinal T lymphocyte homing is associated with gastric emptying and epithelial barrier function in critically ill: a prospective observational study. Crit Care (2017) 0.75
Circulating intestinal fatty acid-binding protein (I-FABP) levels in acute decompensated heart failure. Clin Biochem (2017) 0.75
Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury. PLoS One (2017) 0.75
Evidence for a Cystic Fibrosis Enteropathy. PLoS One (2015) 0.75
I-FABP is a Novel Marker for the Detection of Intestinal Injury in Severely Injured Trauma Patients. World J Surg (2017) 0.75
Determinant Variables, Enteric Pathogen Burden, Gut Function, and Immune-Related Inflammatory Biomarkers Associated with Childhood Malnutrition: A Prospective Case-Control Study in Northeastern Brazil. Pediatr Infect Dis J (2017) 0.75
Biomarkers and non-invasive tests for gastrointestinal mucositis. Support Care Cancer (2017) 0.75
Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta (2005) 2.40
Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J (2004) 2.37
Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation (2003) 1.96
Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J Biol Chem (2007) 1.74
A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem (2004) 1.58
Cathelicidin LL-37: a multitask antimicrobial peptide. Arch Immunol Ther Exp (Warsz) (2010) 1.43
Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim Biophys Acta (2005) 1.40
Regulation of fatty acid transport by fatty acid translocase/CD36. Proc Nutr Soc (2004) 1.38
Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes (2002) 1.38
Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes (2003) 1.37
Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes (2004) 1.35
Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J Physiol (2005) 1.31
Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis. J Biol Chem (2011) 1.30
Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake. Mol Cell Biochem (2002) 1.30
A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am J Physiol Endocrinol Metab (2007) 1.29
Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation. Am J Physiol Endocrinol Metab (2005) 1.29
Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc Res (2008) 1.27
Gene therapy for lipoprotein lipase deficiency: working toward clinical application. Hum Gene Ther (2005) 1.24
Evolution of the family of intracellular lipid binding proteins in vertebrates. Mol Cell Biochem (2002) 1.23
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation. Hum Gene Ther (2004) 1.18
Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. Am J Physiol Endocrinol Metab (2002) 1.17
Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda) (2007) 1.16
Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle. J Biol Chem (2009) 1.13
Extracellular gelsolin binds lipoteichoic acid and modulates cellular response to proinflammatory bacterial wall components. J Immunol (2008) 1.12
Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: influence of physical activity and gender. J Appl Physiol (1985) (2004) 1.11
Fatty acid transport across the cell membrane: regulation by fatty acid transporters. Prostaglandins Leukot Essent Fatty Acids (2010) 1.07
Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein. J Immunol Methods (2003) 1.07
Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. J Antimicrob Chemother (2008) 1.06
AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. Biochem Biophys Res Commun (2007) 1.06
Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters. Pflugers Arch (2004) 1.05
In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am J Physiol Endocrinol Metab (2009) 1.05
Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin Chem (2004) 1.04
Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats. Am J Physiol Regul Integr Comp Physiol (2009) 1.02
Crucial role for LKB1 to AMPKalpha2 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes. Biochim Biophys Acta (2008) 1.01
Critical steps in cellular fatty acid uptake and utilization. Mol Cell Biochem (2002) 1.00
Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. Am J Obstet Gynecol (2008) 1.00
Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm. Am J Physiol Endocrinol Metab (2004) 0.99
Uncoupling protein 3 as a mitochondrial fatty acid anion exporter. FASEB J (2003) 0.99
The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR. FEBS Lett (2005) 0.99
In vivo, fatty acid translocase (CD36) critically regulates skeletal muscle fuel selection, exercise performance, and training-induced adaptation of fatty acid oxidation. J Biol Chem (2012) 0.98
Gender-related differences in the metabolic response to fasting. J Clin Endocrinol Metab (2007) 0.98
In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidation. J Physiol (2010) 0.98
The effect of UCP3 overexpression on mitochondrial ROS production in skeletal muscle of young versus aged mice. FEBS Lett (2008) 0.98
Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Lett (2009) 0.98
FAT/CD36-null mice reveal that mitochondrial FAT/CD36 is required to upregulate mitochondrial fatty acid oxidation in contracting muscle. Am J Physiol Regul Integr Comp Physiol (2009) 0.97
Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts. Mol Cell Biochem (2006) 0.97
Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria. J Physiol (2008) 0.97
Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc Natl Acad Sci U S A (2003) 0.97
Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane. Prostaglandins Leukot Essent Fatty Acids (2008) 0.97
Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability. Am J Physiol Cell Physiol (2010) 0.96
Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle. Am J Physiol Endocrinol Metab (2007) 0.96
New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36. Biochem J (2002) 0.95
Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters. Mol Cell Biochem (2007) 0.95
Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment. Cytokine (2008) 0.95
Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients. Clin Chem (2002) 0.95
Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. Am J Physiol Endocrinol Metab (2002) 0.94
Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice. BMC Microbiol (2009) 0.94
Insulin-induced translocation of CD36 to the plasma membrane is reversible and shows similarity to that of GLUT4. Biochim Biophys Acta (2007) 0.93
High fat diet induced diabetic cardiomyopathy. Prostaglandins Leukot Essent Fatty Acids (2011) 0.92
Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity. Am J Physiol Endocrinol Metab (2007) 0.92
Different mechanisms can alter fatty acid transport when muscle contractile activity is chronically altered. Am J Physiol Endocrinol Metab (2004) 0.92
Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle. J Physiol (2007) 0.92
Muscovite (mica) allows the characterisation of supported bilayers by ellipsometry and confocal fluorescence correlation spectroscopy. Biol Chem (2002) 0.92
Overexpression of membrane-associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism. Physiol Genomics (2004) 0.92
Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes. Cell Mol Life Sci (2011) 0.92
Identification of protein kinase D as a novel contraction-activated kinase linked to GLUT4-mediated glucose uptake, independent of AMPK. Cell Signal (2007) 0.92
Human heart-type fatty acid-binding protein for on-site diagnosis of early acute myocardial infarction. Int J Cardiol (2008) 0.91
Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates. Biochem J (2009) 0.91
Gender differences in pre-hospital time delay and symptom presentation in patients suspected of acute coronary syndrome in primary care. Fam Pract (2011) 0.90
A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism. Am J Physiol Endocrinol Metab (2003) 0.90
Brain arachidonic acid incorporation is decreased in heart fatty acid binding protein gene-ablated mice. Biochemistry (2005) 0.89
Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach. Helicobacter (2007) 0.89
Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa. J Immunol (2011) 0.89
Heart fatty acid uptake is decreased in heart fatty acid-binding protein gene-ablated mice. J Biol Chem (2004) 0.89
Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle. J Physiol (2006) 0.88
Role of saliva in esophageal defense: implications in patients with nonerosive reflux disease. Am J Med Sci (2015) 0.88
Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats. Am J Physiol Endocrinol Metab (2006) 0.88
Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle. J Biol Chem (2001) 0.88
Signalling components involved in contraction-inducible substrate uptake into cardiac myocytes. Proc Nutr Soc (2004) 0.87
Permissive action of protein kinase C-zeta in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes. J Endocrinol (2009) 0.86
Rapid analysis of fatty acid-binding proteins with immunosensors and immunotests for early monitoring of tissue injury. Biosens Bioelectron (2004) 0.86
CD36 is important for adipocyte recruitment and affects lipolysis. Obesity (Silver Spring) (2013) 0.86
Significance of uncoupling protein 3 in mitochondrial function upon mid- and long-term dietary high-fat exposure. FEBS Lett (2011) 0.86
Adenosine monophosphate-activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart. Endocrinology (2009) 0.86
Protein-mediated fatty acid uptake: regulation by contraction, AMP-activated protein kinase, and endocrine signals. Appl Physiol Nutr Metab (2007) 0.85
Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia. FASEB J (2005) 0.85
Protein kinase D1 is essential for contraction-induced glucose uptake but is not involved in fatty acid uptake into cardiomyocytes. J Biol Chem (2011) 0.85
FAT/CD36 expression is not ablated in spontaneously hypertensive rats. J Lipid Res (2008) 0.85
CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes. Biochem J (2012) 0.85
Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats. Biochem J (2003) 0.85
Comparison of perfusate activities of glutathione S-transferase, alanine aminopeptidase and fatty acid binding protein in the assessment of non-heart-beating donor kidneys. Ann Clin Biochem (2003) 0.84
Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres. Histochem Cell Biol (2004) 0.84
Modulation of exogenous antibiotic activity by host cathelicidin LL-37. APMIS (2010) 0.84
Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. Am J Physiol Endocrinol Metab (2011) 0.84
Fatty acid- and cholesterol transporter protein expression along the human intestinal tract. PLoS One (2010) 0.83